الأعمال قيد التحليل بانتظار التحليل الذكي CNBC Business 04 آب 2026, 03:34

Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges

Merck cut its profit guidance due to a charge tied to its acquisition of biotech company Terns Pharmaceuticals.

Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges

لماذا يهم هذا الخبر؟

سيظهر الملخص التحليلي هنا بعد اكتمال معالجة الذكاء الاصطناعي.

سياق الخبر

Merck cut its profit guidance due to a charge tied to its acquisition of biotech company Terns Pharmaceuticals.

فتح الخبر الأصلي
تغطية مرتبطة

المزيد من أخبار الأعمال